{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T06:42:26Z","timestamp":1700980946362},"reference-count":25,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0298","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T08:53:28Z","timestamp":1661504008000},"source":"Crossref","is-referenced-by-count":2,"title":["Self-reported reactogenicity after different COVID-19 vaccination regimens"],"prefix":"10.3238","author":[{"given":"Laura R.","family":"Pfrommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Schoeps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Blettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wollschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Herm-Stapelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Mittnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Kachel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike D.","family":"von Loewenich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio A. L.","family":"Gianicolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"10.3238\/arztebl.m2022.0298_ref1","unstructured":"European Commission: Safe COVID-19 vaccines for Europeans 2022. www.ec.europa.eu\/info\/live-work-travel-eu\/coronavirus-response\/safe-covid-19-vaccines-europeans_en (last accessed on 15 April 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref2","unstructured":"World Health Organisation (WHO): Coronavirus disease (COVID-19): Vaccines. 2022. (last accessed on 12 July 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref3","unstructured":"Bundesministerium f\u00fcr Gesundheit: Wie ist der Fortschritt der COVID-19-Impfung? Aktueller Impfstatus 2022. www.impfdashboard.de\/ (last accessed on 28 July 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref4","doi-asserted-by":"crossref","unstructured":"Nguyen TT, Quach THT, Tran TM, et al.: Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine. Biomed Pharmacother 2022; 147: 112650","DOI":"10.1016\/j.biopha.2022.112650"},{"key":"10.3238\/arztebl.m2022.0298_ref5","doi-asserted-by":"crossref","unstructured":"European Medicines Agency: Safety of COVID-19 vaccines 2022. www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/safety-covid-19-vaccines (last accessed on 15 April 2022).","DOI":"10.1080\/21645515.2023.2263982"},{"key":"10.3238\/arztebl.m2022.0298_ref6","doi-asserted-by":"crossref","unstructured":"Stuart ASV, Shaw RH, Liu X, et al.: Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet 2022; 399: 36\u201349","DOI":"10.1016\/S0140-6736(21)02718-5"},{"key":"10.3238\/arztebl.m2022.0298_ref7","doi-asserted-by":"crossref","unstructured":"Sablerolles RSG, Rietdijk WJR, Goorhuis A, et al.: Immunogenicity and reactogenicity of vaccine boosters after Ad26.COV2.S Priming. N Engl J Med 2022; 386: 951\u201363","DOI":"10.1056\/NEJMoa2116747"},{"key":"10.3238\/arztebl.m2022.0298_ref8","doi-asserted-by":"crossref","unstructured":"Menni C, Klaser K, May A, et al.: Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 2021; 21: 939\u201349","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"10.3238\/arztebl.m2022.0298_ref9","doi-asserted-by":"crossref","unstructured":"Tozzi AE, Asturias EJ, Balakrishnan MR, Halsey NA, Law B, Zuber PLF: Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. Vaccine 2013; 31: 5041\u201346","DOI":"10.1016\/j.vaccine.2013.08.087"},{"key":"10.3238\/arztebl.m2022.0298_ref10","unstructured":"R Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2021."},{"key":"10.3238\/arztebl.m2022.0298_ref11","doi-asserted-by":"crossref","unstructured":"Rosenblum HG, Gee J, Liu R, et al.: Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis 2022; 22: 802\u201312","DOI":"10.1016\/S1473-3099(22)00054-8"},{"key":"10.3238\/arztebl.m2022.0298_ref12","doi-asserted-by":"crossref","unstructured":"Powell AA, Power L, Westrop S, et al.: Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. Euro Surveill 2021; 26: 2100634","DOI":"10.2807\/1560-7917.ES.2021.26.28.2100634"},{"key":"10.3238\/arztebl.m2022.0298_ref13","doi-asserted-by":"crossref","unstructured":"Borobia AM, Carcas AJ, P\u00e9rez-Olmeda M, et al.: Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet 2021; 398: 121\u201330","DOI":"10.1016\/S0140-6736(21)01420-3"},{"key":"10.3238\/arztebl.m2022.0298_ref14","doi-asserted-by":"crossref","unstructured":"Andrew MK, McElhaney JE: Age and frailty in COVID-19 vaccine development. Lancet 2020; 396: 1942\u20134","DOI":"10.1016\/S0140-6736(20)32481-8"},{"key":"10.3238\/arztebl.m2022.0298_ref15","doi-asserted-by":"crossref","unstructured":"McCartney PR: Sex-based vaccine response in the context of COVID-19. J Obstet Gynecol Neonatal Nurs 2020; 49: 405\u20138","DOI":"10.1016\/j.jogn.2020.08.001"},{"key":"10.3238\/arztebl.m2022.0298_ref16","doi-asserted-by":"crossref","unstructured":"Shaw RH, Stuart A, Greenland M, Liu X, Nguyen Van-Tam JS, Snape MD: Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet 2021; 397: 2043\u201346","DOI":"10.1016\/S0140-6736(21)01115-6"},{"key":"10.3238\/arztebl.m2022.0298_ref17","doi-asserted-by":"crossref","unstructured":"Schmidt T, Klemis V, Schub D, et al.: Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination. Nat Med 2021; 27: 1530\u20135","DOI":"10.1038\/s41591-021-01464-w"},{"key":"10.3238\/arztebl.m2022.0298_ref18","doi-asserted-by":"crossref","unstructured":"Benning L, T\u00f6llner M, Hidmark A, et al.: Heterologous ChAdOx1 nCoV-19\/BNT162b2 prime-boost vaccination induces strong humoral responses among health care workers. Vaccines (Basel) 2021; 9: 857","DOI":"10.3390\/vaccines9080857"},{"key":"10.3238\/arztebl.m2022.0298_ref19","doi-asserted-by":"crossref","unstructured":"Normark J, Vikstr\u00f6m L, Gwon Y-D, et al.: Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination. N Engl J Med 2021; 385: 1049\u201351","DOI":"10.1056\/NEJMc2110716"},{"key":"10.3238\/arztebl.m2022.0298_ref20","doi-asserted-by":"crossref","unstructured":"Hillus D, Schwarz T, Tober-Lau P, et al.: Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med 2021; 9: 1255\u201365","DOI":"10.1016\/S2213-2600(21)00357-X"},{"key":"10.3238\/arztebl.m2022.0298_ref21","doi-asserted-by":"crossref","unstructured":"Amanzio M, Mitsikostas DD, Giovannelli F, Bartoli M, Cipriani GE, Brown WA: Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: a systematic review. Lancet Reg Health Eur 2022; 12: 100253","DOI":"10.1016\/j.lanepe.2021.100253"},{"key":"10.3238\/arztebl.m2022.0298_ref22","unstructured":"St\u00e4ndige Impfkomission: Pressemitteilung der STIKO zum AstraZeneca-Impfstoff (30.03.2021). 2021. www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/AstraZeneca-Impfstoff-2021-03-30.html (last accessed on 15 April 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref23","unstructured":"St\u00e4ndige Impfkomission: Pressemitteilung der STIKO zur COVID-19-Impfung mit mRNA-Impfstoff bei Personen unter 30 Jahren (10.11.2021) 2021. www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/PM_2021-11-10.html (last accessed on 15 April 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref24","unstructured":"Our World in Data: Coronavirus (COVID-19) Vaccinations, 2022. www.ourworldindata.org\/covid-vaccinations (last accessed on 11 April 2022)."},{"key":"10.3238\/arztebl.m2022.0298_ref25","unstructured":"Xing K, Tu X-Y, Liu M, et al.: Efficacy and safety of COVID-19 vaccines: a systematic review. CJCP 2021; 23: 221\u20138"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T06:05:48Z","timestamp":1700978748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0298","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}